BioSpace News Archive

Nephros, Inc., a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, announced the appointment of Wes Lobo as Chief Marketing Officer, reporting directly to Nephros Chief Executive Officer, Andy Astor.

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will report its fourth quarter and full year 2020 financial results on Thursday, February 25, 2021.

Intellia Therapeutics, Inc., a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present its fourth quarter and full-year 2020 financial results and operational highlights in a conference call on February 25, 2021 at 8 a.m. ET.

Translate Bio announced that Ronald Renaud, chief executive officer, will participate in a fireside chat at the SVB Leerink Virtual 10th Annual Global Healthcare Conference on Friday, February 26, 2021 at 9:20 a.m. EST.

Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, announced that it will report its fourth quarter and full year 2020 financial results on February 25, 2021 before the opening of the U.S. financial markets.

Neuralgia is an abnormal symptom with effects like sharp, burning, and mostly severe pain, due to an irritated or damaged nerve.

Fact.MR, Rockville: Fact.MR’s new research study on Factor XIII deficiency market reveals key insights on latest R&D, and their likely commercial impact.

Health care professionals readily use connected injectable drug delivery devices, which help them record dosing patterns of patients.

The global home health hubs market is driven by the increase in geriatric population, which has led to a rise in prevalence of chronic diseases, lack or shortage of healthcare professionals, and reduced cost of healthcare

The makers of Senseon® have unveiled their latest access control innovation for the healthcare market in response to the evolving needs of the healthcare industry due to the COVID-19 pandemic.